Pro Medicus Limited
PME
Rang in Aktien
#1628
Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a... Established in 1983 and based in Richmond, Australia, Pro Medicus Limited is a leading provider of medical imaging software and services. The company develops and delivers advanced solutions to hospitals, diagnostic imaging groups, and other healthcare organizations across Australia, North America, and Europe. Their core offerings include proprietary Radiology Information Systems (RIS), which streamline practice management and come with comprehensive support, training, installation, and professional services. Pro Medicus also operates Promedicus.net, an e-health platform, and supplies sophisticated imaging software designed to provide radiologists and clinicians with powerful visualization capabilities for 2D, 3D, and 4D medical images. This suite of tools is further enhanced by Picture Archiving and Communication System (PACS)/digital imaging software and integration products. Additionally, they offer mobile applications like Visage Ease Pro, which enables remote interpretation of diagnostic imaging studies stored on a Visage 7 server. Key product brands include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease.
Aktienkurs
$126.25
Marktkapitalisierung
$13.19B
Veränderung (1 Tag)
-0.30%
Veränderung (1 Jahr)
-32.46%
Land
AU
Handel Pro Medicus Limited (PME)
Kategorie
Healthcare
Gewinn für Pro Medicus Limited (PME)
Gewinn im Jun 2026 TTM: $266.26M
Laut den aktuellen Finanzberichten von Pro Medicus Limited betragen die aktuellen Gewinne des Unternehmens $266.26M. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $77.79M, eine Steigerung gegenüber dem Gewinn im Jahr 2023, der $57.38M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Pro Medicus Limited von 2000 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $266.26M | 147.66% |
| 2025 | $107.51M | 38.21% |
| 2024 | $77.79M | 35.55% |
| 2023 | $57.38M | 31.89% |
| 2022 | $43.51M | 35.35% |
| 2021 | $32.15M | 55.19% |
| 2020 | $20.71M | 12.91% |
| 2019 | $18.35M | 61.89% |
| 2018 | $11.33M | 9.72% |
| 2017 | $10.33M | 45.98% |
| 2016 | $7.07M | 79.75% |
| 2015 | $3.94M | 70.17% |
| 2014 | $2.31M | -151.63% |
| 2013 | $-4.48M | -530.12% |
| 2012 | $1.04M | 38.76% |
| 2011 | $750.57K | -84.46% |
| 2010 | $4.83M | -24.83% |
| 2009 | $6.42M | -40.86% |
| 2008 | $10.86M | 31.35% |
| 2007 | $8.27M | 29.34% |
| 2006 | $6.39M | 9.18% |
| 2005 | $5.86M | 68.01% |
| 2004 | $3.49M | -19.23% |
| 2003 | $4.32M | 13.36% |
| 2002 | $3.81M | 19.88% |
| 2001 | $3.18M | 2.97% |
| 2000 | $3.08M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $2.04B | 667.30% |
US
|
|
| $295.53M | 11.00% |
US
|
|
| $-259.89M | -197.61% |
US
|
|
| $-74.89M | -128.13% |
US
|
|
| - | - |
US
|
